MedPath

Single-center, open, randomized controlled trial about Chinese fasting therapy in the reversal of type 2 diabetes with overweight or obesity

Phase 1
Recruiting
Conditions
Type 2 Diabetes with Overweight or Obesity
Registration Number
ITMCTR2100004961
Lead Sponsor
The Seventh Affiliated Hospital of Sun Yat-sen University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1.Parient is aged 18 to 70 years;
2.According to the Chinese Guidelines of Type 2 Diabetes (2017 Edition), type 2 diabetes lasts within six years with overweight or obesity: 24kg/m^2 <= BMI <= 35kg/m^2;
3.Heart, liver, and kidney function is normal;
4.Signed the informed consent form.
All the above four items conformed can enter the group.

Exclusion Criteria

1.Patient has received insulin intensive therapy;
2.Pregnancy, lactation, or menstrual women;
3.Malignant tumor and hematonosis;
4.Patients with active tuberculosis;
5.Patients with ulcers with severe gastric bleeding;
6.Recently glylated hemoglobin >= 12%;
7.Other circumstances that investigators judging not suitable for inclusion.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
remission rate of blood sugar;
Secondary Outcome Measures
NameTimeMethod
weight loss range;
© Copyright 2025. All Rights Reserved by MedPath